<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">psychiatry</journal-id><journal-title-group><journal-title xml:lang="ru">ПСИХИАТРИЯ</journal-title><trans-title-group xml:lang="en"><trans-title>Psychiatry (Moscow) (Psikhiatriya)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1683-8319</issn><issn pub-type="epub">2618-6667</issn><publisher><publisher-name>FSBSI “The Mental Health Research Centre”;   LLC «Publisher «MIA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2618-6667-2025-23-4-81-92</article-id><article-id custom-type="elpub" pub-id-type="custom">psychiatry-1423</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>Migraine and Dementia: A Narrative Review of Current Evidence</article-title><trans-title-group xml:lang="en"><trans-title>Migraine and Dementia: A Narrative Review of Current Evidence</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0028-8185</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Choudhary</surname><given-names>A. K.</given-names></name><name name-style="western" xml:lang="en"><surname>Choudhary</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Dr. Arbind Kumar Choudhary, PhD, Associate Professor, Dept. of Physiology</p><p>Raebareli, Uttar Pradesh</p></bio><bio xml:lang="en"><p>Dr. Arbind Kumar Choudhary, PhD, Associate Professor, Dept. of Physiology</p><p>Raebareli, Uttar Pradesh</p></bio><email xlink:type="simple">arbindchoudhary111@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>All India Institute of Medical Science</institution><country>Индия</country></aff><aff xml:lang="en"><institution>All India Institute of Medical Science</institution><country>India</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2025</year></pub-date><volume>23</volume><issue>4</issue><fpage>81</fpage><lpage>92</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Choudhary A.K., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Choudhary A.K.</copyright-holder><copyright-holder xml:lang="en">Choudhary A.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.journalpsychiatry.com/jour/article/view/1423">https://www.journalpsychiatry.com/jour/article/view/1423</self-uri><abstract><p>Background: Migraine is a common neurological disorder characterized by recurrent headaches, while dementia is a progressive neurodegenerative condition leading to cognitive decline. Recent studies indicate that these conditions may share common underlying mechanisms, such as vascular dysfunction, Neuroinflammation, oxidative stress, and structural brain changes, all of which could contribute to cognitive impairment. The aim was to explore the potential connection between migraine, particularly migraine with aura, and an augmented risk of dementia. Material and Methods: the keywords Migraine, Dementia, Vascular Dysfunction, Neuroinflammation, Oxidative Stress, Cognitive Decline are used to search for articles in the PubMed and others databases for the period from 2000 to 2024. Conclusions: studies on the general population indicate that those who suffer from migraines, particularly those who have aura, may be more susceptible to dementia, including vascular and Alzheimer’s diseases. However, the results are inconclusive, and further research is needed to understand this potential link. Shared mechanisms like endothelial dysfunction, neuroinflammation, and oxidative stress provide evidence of a connection between migraine and dementia. This potential link has significant clinical implications. Patients with a history of migraine should have their mental health closely watched by medical professionals, especially if they experience frequent auras or chronic migraines. Addressing vascular risk factors, improving migraine management, and informing patients about potential risks can help reduce the likelihood of developing dementia. Future investigations should focus on longitudinal studies to track the progression of migraine and dementia, mechanistic studies to understand the underlying pathways, genetic studies to identify shared susceptibility, and clinical trials to evaluate interventions aimed at reducing dementia risk in individuals with migraines. Public health initiatives aimed at raising awareness and promoting early intervention are crucial in influencing the prevalence of dementia in individuals with migraines.</p></abstract><trans-abstract xml:lang="en"><p>Background: Migraine is a common neurological disorder characterized by recurrent headaches, while dementia is a progressive neurodegenerative condition leading to cognitive decline. Recent studies indicate that these conditions may share common underlying mechanisms, such as vascular dysfunction, Neuroinflammation, oxidative stress, and structural brain changes, all of which could contribute to cognitive impairment. The aim was to explore the potential connection between migraine, particularly migraine with aura, and an augmented risk of dementia. Material and Methods: the keywords Migraine, Dementia, Vascular Dysfunction, Neuroinflammation, Oxidative Stress, Cognitive Decline are used to search for articles in the PubMed and others databases for the period from 2000 to 2024. Conclusions: studies on the general population indicate that those who suffer from migraines, particularly those who have aura, may be more susceptible to dementia, including vascular and Alzheimer’s diseases. However, the results are inconclusive, and further research is needed to understand this potential link. Shared mechanisms like endothelial dysfunction, neuroinflammation, and oxidative stress provide evidence of a connection between migraine and dementia. This potential link has significant clinical implications. Patients with a history of migraine should have their mental health closely watched by medical professionals, especially if they experience frequent auras or chronic migraines. Addressing vascular risk factors, improving migraine management, and informing patients about potential risks can help reduce the likelihood of developing dementia. Future investigations should focus on longitudinal studies to track the progression of migraine and dementia, mechanistic studies to understand the underlying pathways, genetic studies to identify shared susceptibility, and clinical trials to evaluate interventions aimed at reducing dementia risk in individuals with migraines. Public health initiatives aimed at raising awareness and promoting early intervention are crucial in influencing the prevalence of dementia in individuals with migraines.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Migraine</kwd><kwd>Dementia</kwd><kwd>Vascular Dysfunction</kwd><kwd>Neuroinflammation</kwd><kwd>Oxidative Stress</kwd><kwd>Cognitive Decline</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Migraine</kwd><kwd>Dementia</kwd><kwd>Vascular Dysfunction</kwd><kwd>Neuroinflammation</kwd><kwd>Oxidative Stress</kwd><kwd>Cognitive Decline</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Leonardi M, Martelletti P, Burstein R, Fornari A, Grazzi L, Guekht A, Lipton RB, Mitsikostas DD, Olesen J, Owolabi MO, Ruiz De la Torre E, Sacco S, Steiner TJ, Surya N, Takeshima T, Tassorelli C, Wang SJ, Wijeratne T, Yu S, Raggi A. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders. J Headache Pain. 2024;25(1):4. doi: 10.1186/s10194-023-01700-3 PMID: 38178049; PMCID: PMC10768290.</mixed-citation><mixed-citation xml:lang="en">Leonardi M, Martelletti P, Burstein R, Fornari A, Grazzi L, Guekht A, Lipton RB, Mitsikostas DD, Olesen J, Owolabi MO, Ruiz De la Torre E, Sacco S, Steiner TJ, Surya N, Takeshima T, Tassorelli C, Wang SJ, Wijeratne T, Yu S, Raggi A. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders. J Headache Pain. 2024;25(1):4. doi: 10.1186/s10194-023-01700-3 PMID: 38178049; PMCID: PMC10768290.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Larson EB. Evaluation of cognitive impairment and dementia. UpToDate. Waltham, MA: UpToDate, 2016.</mixed-citation><mixed-citation xml:lang="en">Larson EB. Evaluation of cognitive impairment and dementia. UpToDate. Waltham, MA: UpToDate, 2016.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–608. doi: 10.1016/j.arc-med.2012.11.003 Epub 2012 Nov 15. PMID: 23159715.</mixed-citation><mixed-citation xml:lang="en">Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–608. doi: 10.1016/j.arc-med.2012.11.003 Epub 2012 Nov 15. PMID: 23159715.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Cao Z, Nandi A, Counts N, Jiao L, Prettner K, Kuhn M, Seligman B, Tortorice D, Vigo D, Wang C, Bloom DE. The global macroeconomic burden of Alzheimer’s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob Health. 2024;12(9):e1534–e1543. doi: 10.1016/S2214-109X(24)00264-X PMID: 39151988.</mixed-citation><mixed-citation xml:lang="en">Chen S, Cao Z, Nandi A, Counts N, Jiao L, Prettner K, Kuhn M, Seligman B, Tortorice D, Vigo D, Wang C, Bloom DE. The global macroeconomic burden of Alzheimer’s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob Health. 2024;12(9):e1534–e1543. doi: 10.1016/S2214-109X(24)00264-X PMID: 39151988.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Wu JC, Wang FY, Chen X, Wang Y. Meta-analysis of association between migraine and risk of dementia. Acta Neurol Scand. 2022;145(1):87–93. doi: 10.1111/ane.13528 Epub 2021 Sep 15. PMID: 34523724.</mixed-citation><mixed-citation xml:lang="en">Wang L, Wu JC, Wang FY, Chen X, Wang Y. Meta-analysis of association between migraine and risk of dementia. Acta Neurol Scand. 2022;145(1):87–93. doi: 10.1111/ane.13528 Epub 2021 Sep 15. PMID: 34523724.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Innes KE, Sambamoorthi U. The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline, New Onset Cognitive Impairment, and Incident Dementia: A Systematic Review and Conceptual Model for Future Research. J Alzheimers Dis. 2020;78(3):1177–1195. doi: 10.3233/JAD-200960 PMID: 33252087; PMCID: PMC7992129.</mixed-citation><mixed-citation xml:lang="en">Innes KE, Sambamoorthi U. The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline, New Onset Cognitive Impairment, and Incident Dementia: A Systematic Review and Conceptual Model for Future Research. J Alzheimers Dis. 2020;78(3):1177–1195. doi: 10.3233/JAD-200960 PMID: 33252087; PMCID: PMC7992129.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lucas C. Migraine with aura. Rev Neurol (Paris). 2021;177(7):779–784. doi: 10.1016/j.neurol.2021.07.010 Epub 2021 Aug 9. PMID: 34384631.</mixed-citation><mixed-citation xml:lang="en">Lucas C. Migraine with aura. Rev Neurol (Paris). 2021;177(7):779–784. doi: 10.1016/j.neurol.2021.07.010 Epub 2021 Aug 9. PMID: 34384631.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SY, Lim JS, Oh DJ, Kong IG, Choi HG. Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort. Medicine (Baltimore). 2019;98(7):e14467. doi: 10.1097/MD.0000000000014467 PMID: 30762763; PMCID: PMC6408076.</mixed-citation><mixed-citation xml:lang="en">Lee SY, Lim JS, Oh DJ, Kong IG, Choi HG. Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort. Medicine (Baltimore). 2019;98(7):e14467. doi: 10.1097/MD.0000000000014467 PMID: 30762763; PMCID: PMC6408076.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cipriani G, Danti S, Picchi L, Nuti A, Fiorino MD. Daily functioning and dementia. Dement Neuropsychol. 2020;14(2):93–102. doi: 10.1590/1980-57642020dn14-020001 PMID: 32595877; PMCID: PMC7304278.</mixed-citation><mixed-citation xml:lang="en">Cipriani G, Danti S, Picchi L, Nuti A, Fiorino MD. Daily functioning and dementia. Dement Neuropsychol. 2020;14(2):93–102. doi: 10.1590/1980-57642020dn14-020001 PMID: 32595877; PMCID: PMC7304278.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lee HJ, Yu H, Gil Myeong S, Park K, Kim DK. Midand Late-Life Migraine Is Associated with an Increased Risk of All-Cause Dementia and Alzheimer’s Disease, but Not Vascular Dementia: A Nationwide Retrospective Cohort Study. J Pers Med. 2021;11(10):990. doi: 10.3390/jpm11100990 PMID: 34683131; PMCID: PMC8540823.</mixed-citation><mixed-citation xml:lang="en">Lee HJ, Yu H, Gil Myeong S, Park K, Kim DK. Midand Late-Life Migraine Is Associated with an Increased Risk of All-Cause Dementia and Alzheimer’s Disease, but Not Vascular Dementia: A Nationwide Retrospective Cohort Study. J Pers Med. 2021;11(10):990. doi: 10.3390/jpm11100990 PMID: 34683131; PMCID: PMC8540823.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Islamoska S, Hansen JM, Hansen ÅM, Garde AH, Waldemar G, Nabe-Nielsen K. The association between migraine and dementia — a national register-based matched cohort study. Public Health. 2022;213:54– 60. doi: 10.1016/j.puhe.2022.09.018 Epub 2022 Nov 6. PMID: 36351328.</mixed-citation><mixed-citation xml:lang="en">Islamoska S, Hansen JM, Hansen ÅM, Garde AH, Waldemar G, Nabe-Nielsen K. The association between migraine and dementia — a national register-based matched cohort study. Public Health. 2022;213:54– 60. doi: 10.1016/j.puhe.2022.09.018 Epub 2022 Nov 6. PMID: 36351328.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gustavsson A, Norton N, Fast T, Frölich L, Georges J, Holzapfel D, Kirabali T, Krolak-Salmon P, Rossini PM, Ferretti MT, Lanman L, Chadha AS, van der Flier WM. Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimers Dement. 2023;19(2):658–670. doi: 10.1002/alz.12694 Epub 2022 Jun 2. PMID: 35652476.</mixed-citation><mixed-citation xml:lang="en">Gustavsson A, Norton N, Fast T, Frölich L, Georges J, Holzapfel D, Kirabali T, Krolak-Salmon P, Rossini PM, Ferretti MT, Lanman L, Chadha AS, van der Flier WM. Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimers Dement. 2023;19(2):658–670. doi: 10.1002/alz.12694 Epub 2022 Jun 2. PMID: 35652476.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang W, Liang GH, Li JA, Yu P, Dong M. Migraine and the risk of dementia: a meta-analysis and systematic review. Aging Clin Exp Res. 2022;34(6):1237–1246. doi: 10.1007/s40520-021-02065-w Epub 2022 Jan 31. PMID: 35102514.</mixed-citation><mixed-citation xml:lang="en">Jiang W, Liang GH, Li JA, Yu P, Dong M. Migraine and the risk of dementia: a meta-analysis and systematic review. Aging Clin Exp Res. 2022;34(6):1237–1246. doi: 10.1007/s40520-021-02065-w Epub 2022 Jan 31. PMID: 35102514.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Maity MK, Naagar M. A Review on Headache: Epidemiology, Pathophysiology, Classifications, Diagnosis, Clinical Management and Treatment Modalities. International Journal of Science and Research (IJSR). 2022;11(7):506–515.</mixed-citation><mixed-citation xml:lang="en">Maity MK, Naagar M. A Review on Headache: Epidemiology, Pathophysiology, Classifications, Diagnosis, Clinical Management and Treatment Modalities. International Journal of Science and Research (IJSR). 2022;11(7):506–515.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, Krymchantowski AV, Lebedeva ER, Ravishankar K, Yu S, Sacco S, Ashina S, Younis S, Steiner TJ, Lipton RB. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485–1495. doi: 10.1016/S0140-6736(20)32160-7 Epub 2021 Mar 25. PMID: 33773613.</mixed-citation><mixed-citation xml:lang="en">Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, Krymchantowski AV, Lebedeva ER, Ravishankar K, Yu S, Sacco S, Ashina S, Younis S, Steiner TJ, Lipton RB. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485–1495. doi: 10.1016/S0140-6736(20)32160-7 Epub 2021 Mar 25. PMID: 33773613.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci. 2020;41(2):429–436. doi: 10.1007/s10072-020-04643-8 PMID: 32845494; PMCID: PMC7704513.</mixed-citation><mixed-citation xml:lang="en">Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci. 2020;41(2):429–436. doi: 10.1007/s10072-020-04643-8 PMID: 32845494; PMCID: PMC7704513.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shimizu T, Sakai F, Miyake H, Sone T, Sato M, Tanabe S, Azuma Y, Dodick DW. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021;22(1):29. doi: 10.1186/s10194-021-01243-5 PMID: 33882816; PMCID: PMC8061063.</mixed-citation><mixed-citation xml:lang="en">Shimizu T, Sakai F, Miyake H, Sone T, Sato M, Tanabe S, Azuma Y, Dodick DW. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021;22(1):29. doi: 10.1186/s10194-021-01243-5 PMID: 33882816; PMCID: PMC8061063.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lantéri-Minet M, Braschinsky M, Del Rio MS, Daniel O, Özge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501–514. doi: 10.1038/s41582-021-00509-5 Epub 2021 Jun 18. PMID: 34145431; PMCID: PMC8321897.</mixed-citation><mixed-citation xml:lang="en">Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lantéri-Minet M, Braschinsky M, Del Rio MS, Daniel O, Özge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501–514. doi: 10.1038/s41582-021-00509-5 Epub 2021 Jun 18. PMID: 34145431; PMCID: PMC8321897.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2020. doi: 10.1111/head.13966 Epub ahead of print. PMID: 33090481.</mixed-citation><mixed-citation xml:lang="en">Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2020. doi: 10.1111/head.13966 Epub ahead of print. PMID: 33090481.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2020;40(4):399– 406. doi: 10.1177/0333102419877171 Epub 2019 Sep 22. PMID: 31544467.</mixed-citation><mixed-citation xml:lang="en">Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2020;40(4):399– 406. doi: 10.1177/0333102419877171 Epub 2019 Sep 22. PMID: 31544467.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris). 2021;177(7):821–826. doi: 10.1016/j.neurol.2021.07.007 Epub 2021 Jul 27. PMID: 34325915.</mixed-citation><mixed-citation xml:lang="en">Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris). 2021;177(7):821–826. doi: 10.1016/j.neurol.2021.07.007 Epub 2021 Jul 27. PMID: 34325915.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurol Ther. 2022;11(2):553–569. doi: 10.1007/s40120-022-00338-8 Epub 2022 Mar 14. PMID: 35286590; PMCID: PMC9095793.</mixed-citation><mixed-citation xml:lang="en">Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurol Ther. 2022;11(2):553–569. doi: 10.1007/s40120-022-00338-8 Epub 2022 Mar 14. PMID: 35286590; PMCID: PMC9095793.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Chaudhry A, Houlden H, Rizig M. Novelfluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer’s disease: A systematic review. J Neurol Sci. 2020;415:116886. doi: 10.1016/j.jns.2020.116886 Epub 2020 May 11. PMID: 32428759.</mixed-citation><mixed-citation xml:lang="en">Chaudhry A, Houlden H, Rizig M. Novelfluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer’s disease: A systematic review. J Neurol Sci. 2020;415:116886. doi: 10.1016/j.jns.2020.116886 Epub 2020 May 11. PMID: 32428759.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Webster C. What is dementia, why make a diagnosis and what are the current roadblocks. World Alzheimer Report, 2021:147–168.</mixed-citation><mixed-citation xml:lang="en">Webster C. What is dementia, why make a diagnosis and what are the current roadblocks. World Alzheimer Report, 2021:147–168.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">George KM, Folsom AR, Sharrett AR, Mosley TH, Gottesman RF, Hamedani AG, Lutsey PL. Migraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study. Headache. 2020;60(5):946–953. doi: 10.1111/head.13794 Epub 2020 Mar 22. PMID: 32200562; PMCID: PMC7192135.</mixed-citation><mixed-citation xml:lang="en">George KM, Folsom AR, Sharrett AR, Mosley TH, Gottesman RF, Hamedani AG, Lutsey PL. Migraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study. Headache. 2020;60(5):946–953. doi: 10.1111/head.13794 Epub 2020 Mar 22. PMID: 32200562; PMCID: PMC7192135.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Gu L, Wang Y, Shu H. Association between migraine and cognitive impairment. J Headache Pain. 2022;23(1):88. doi: 10.1186/s10194-022-01462-4 PMID: 35883043; PMCID: PMC9317452.</mixed-citation><mixed-citation xml:lang="en">Gu L, Wang Y, Shu H. Association between migraine and cognitive impairment. J Headache Pain. 2022;23(1):88. doi: 10.1186/s10194-022-01462-4 PMID: 35883043; PMCID: PMC9317452.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Velandia PP, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, Tsakalos G, Wimo A, Dieleman JL. Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise. EClinicalMedicine. 2022;45:101337. doi: 10.1016/j.eclinm.2022.101337 PMID: 35299657; PMCID: PMC8921543.</mixed-citation><mixed-citation xml:lang="en">Velandia PP, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, Tsakalos G, Wimo A, Dieleman JL. Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise. EClinicalMedicine. 2022;45:101337. doi: 10.1016/j.eclinm.2022.101337 PMID: 35299657; PMCID: PMC8921543.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Cao Q, Tan CC, Xu W, Hu H, Cao XP, Dong Q, Tan L, Yu JT. The Prevalence of Dementia: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2020;73(3):1157– 1166. doi: 10.3233/JAD-191092 PMID: 31884487.</mixed-citation><mixed-citation xml:lang="en">Cao Q, Tan CC, Xu W, Hu H, Cao XP, Dong Q, Tan L, Yu JT. The Prevalence of Dementia: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2020;73(3):1157– 1166. doi: 10.3233/JAD-191092 PMID: 31884487.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022;12:800605. doi: 10.3389/fneur.2021.800605 PMID: 35281991; PMCID: PMC8904749.</mixed-citation><mixed-citation xml:lang="en">Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022;12:800605. doi: 10.3389/fneur.2021.800605 PMID: 35281991; PMCID: PMC8904749.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kesserwani H. Migraine Triggers: An Overview of the Pharmacology, Biochemistry, Atmospherics, and Their Effects on Neural Networks. Cureus. 2021;13(4):e14243. doi: 10.7759/cureus.14243 PMID: 33954064; PMCID: PMC8088284.</mixed-citation><mixed-citation xml:lang="en">Kesserwani H. Migraine Triggers: An Overview of the Pharmacology, Biochemistry, Atmospherics, and Their Effects on Neural Networks. Cureus. 2021;13(4):e14243. doi: 10.7759/cureus.14243 PMID: 33954064; PMCID: PMC8088284.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Biscetti L, Cresta E, Cupini LM, Calabresi P, Sarchielli P. The putative role of neuroinflammation in the complex pathophysiology of migraine: From bench to bedside. Neurobiol Dis. 2023;180:106072. doi: 10.1016/j.nbd.2023.106072 Epub 2023 Mar 11. PMID: 36907522.</mixed-citation><mixed-citation xml:lang="en">Biscetti L, Cresta E, Cupini LM, Calabresi P, Sarchielli P. The putative role of neuroinflammation in the complex pathophysiology of migraine: From bench to bedside. Neurobiol Dis. 2023;180:106072. doi: 10.1016/j.nbd.2023.106072 Epub 2023 Mar 11. PMID: 36907522.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sudershan A, Younis M, Sudershan S, Kumar P. Migraine as an inflammatory disorder with microglial activation as a prime candidate. Neurol Res. 2023;45(3):200–215. doi: 10.1080/01616412.2022.2129774 Epub 2022 Oct 5. PMID: 36197286.</mixed-citation><mixed-citation xml:lang="en">Sudershan A, Younis M, Sudershan S, Kumar P. Migraine as an inflammatory disorder with microglial activation as a prime candidate. Neurol Res. 2023;45(3):200–215. doi: 10.1080/01616412.2022.2129774 Epub 2022 Oct 5. PMID: 36197286.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bohra SK, Achar RR, Chidambaram SB, Pellegrino C, Laurin J, Masoodi M, Srinivasan A. Current perspectives on mitochondrial dysfunction in migraine. Eur J Neurosci. 2022;56(1):3738–3754. doi: 10.1111/ejn.15676 Epub 2022 May 12. PMID: 35478208.</mixed-citation><mixed-citation xml:lang="en">Bohra SK, Achar RR, Chidambaram SB, Pellegrino C, Laurin J, Masoodi M, Srinivasan A. Current perspectives on mitochondrial dysfunction in migraine. Eur J Neurosci. 2022;56(1):3738–3754. doi: 10.1111/ejn.15676 Epub 2022 May 12. PMID: 35478208.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Schneider JA. Neuropathology of Dementia Disorders. Continuum (Minneap Minn). 2022;28(3):834– 851. doi: 10.1212/CON.0000000000001137 PMID: 35678405; PMCID: PMC10278955.</mixed-citation><mixed-citation xml:lang="en">Schneider JA. Neuropathology of Dementia Disorders. Continuum (Minneap Minn). 2022;28(3):834– 851. doi: 10.1212/CON.0000000000001137 PMID: 35678405; PMCID: PMC10278955.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Erdener ŞE, Kaya Z, Dalkara T. Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. J Headache Pain. 2021;22(1):138. doi: 10.1186/s10194-021-01353-0 PMID: 34794382; PMCID: PMC8600694.</mixed-citation><mixed-citation xml:lang="en">Erdener ŞE, Kaya Z, Dalkara T. Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. J Headache Pain. 2021;22(1):138. doi: 10.1186/s10194-021-01353-0 PMID: 34794382; PMCID: PMC8600694.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Vyas J, Raytthatha N, Prajapati BG. Amyloid cascade hypothesis, tau synthesis, and role of oxidative stress in AD. In: Alzheimer’s Disease and Advanced Drug Delivery Strategies, 2024:73–92.</mixed-citation><mixed-citation xml:lang="en">Vyas J, Raytthatha N, Prajapati BG. Amyloid cascade hypothesis, tau synthesis, and role of oxidative stress in AD. In: Alzheimer’s Disease and Advanced Drug Delivery Strategies, 2024:73–92.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Liu Y, Hu G, Kang L, Ran Y, Su M, Yu S. Cognitive impairment in a classical rat model of chronic migraine may be due to alterations in hippocampal synaptic plasticity and N-methyl-D-aspartate receptor subunits. Mol Pain. 2020;16:1744806920959582. doi: 10.1177/1744806920959582 PMID: 32869707; PMCID: PMC7517984.</mixed-citation><mixed-citation xml:lang="en">Zhang M, Liu Y, Hu G, Kang L, Ran Y, Su M, Yu S. Cognitive impairment in a classical rat model of chronic migraine may be due to alterations in hippocampal synaptic plasticity and N-methyl-D-aspartate receptor subunits. Mol Pain. 2020;16:1744806920959582. doi: 10.1177/1744806920959582 PMID: 32869707; PMCID: PMC7517984.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodríguez I, Cadena-Suárez AR, Sánchez-Garibay C, Pozo-Molina G, Méndez-Catalá CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Muñoz J, Soto-Rojas LO. Alzheimer’s Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023;24(4):3754. doi: 10.3390/ijms24043754 PMID: 36835161; PMCID: PMC9966419.</mixed-citation><mixed-citation xml:lang="en">Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodríguez I, Cadena-Suárez AR, Sánchez-Garibay C, Pozo-Molina G, Méndez-Catalá CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Muñoz J, Soto-Rojas LO. Alzheimer’s Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023;24(4):3754. doi: 10.3390/ijms24043754 PMID: 36835161; PMCID: PMC9966419.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging Concepts in Vascular Dementia: A Review. J Stroke Cerebrovasc Dis. 2021;30(8):105864. doi: 10.1016/j.jstrokecerebrovasdis.2021.105864 Epub 2021 May 29. PMID: 34062312.</mixed-citation><mixed-citation xml:lang="en">Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging Concepts in Vascular Dementia: A Review. J Stroke Cerebrovasc Dis. 2021;30(8):105864. doi: 10.1016/j.jstrokecerebrovasdis.2021.105864 Epub 2021 May 29. PMID: 34062312.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Leak RK, Clark RN, Abbas M, Xu F, Brodsky JL, Chen J, Hu X, Luk KC. Current insights and assumptions on α-synuclein in Lewy body disease. Acta Neuropathol. 2024;148(1):18. doi: 10.1007/s00401-024-02781-3 PMID: 39141121; PMCID: PMC11324801.</mixed-citation><mixed-citation xml:lang="en">Leak RK, Clark RN, Abbas M, Xu F, Brodsky JL, Chen J, Hu X, Luk KC. Current insights and assumptions on α-synuclein in Lewy body disease. Acta Neuropathol. 2024;148(1):18. doi: 10.1007/s00401-024-02781-3 PMID: 39141121; PMCID: PMC11324801.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Upadhyay A, Sundaria N, Dhiman R, Prajapati VK, Prasad A, Mishra A. Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges. Neuroscientist. 2022;28(3):271–282. doi: 10.1177/1073858421989582 Epub 2021 Feb 3. PMID: 33530848.</mixed-citation><mixed-citation xml:lang="en">Upadhyay A, Sundaria N, Dhiman R, Prajapati VK, Prasad A, Mishra A. Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges. Neuroscientist. 2022;28(3):271–282. doi: 10.1177/1073858421989582 Epub 2021 Feb 3. PMID: 33530848.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Goedert M, Spillantini MG, Falcon B, Zhang W, Newell KL, Hasegawa M, Scheres SHW, Ghetti B. Tau Protein and Frontotemporal Dementias. Adv Exp Med Biol. 2021;1281:177–199. doi: 10.1007/978-3-030-51140-1_12 PMID: 33433876</mixed-citation><mixed-citation xml:lang="en">Goedert M, Spillantini MG, Falcon B, Zhang W, Newell KL, Hasegawa M, Scheres SHW, Ghetti B. Tau Protein and Frontotemporal Dementias. Adv Exp Med Biol. 2021;1281:177–199. doi: 10.1007/978-3-030-51140-1_12 PMID: 33433876</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E, Costăchescu B, Grumezescu AM, Teleanu RI. An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases. Int J Mol Sci. 2022;23(11):5938. doi: 10.3390/ijms23115938 PMID: 35682615; PMCID: PMC9180653.</mixed-citation><mixed-citation xml:lang="en">Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E, Costăchescu B, Grumezescu AM, Teleanu RI. An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases. Int J Mol Sci. 2022;23(11):5938. doi: 10.3390/ijms23115938 PMID: 35682615; PMCID: PMC9180653.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Wendimu MY, Hooks SB. Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells. 2022;11(13):2091. doi: 10.3390/cells11132091 PMID: 35805174; PMCID: PMC9266143.</mixed-citation><mixed-citation xml:lang="en">Wendimu MY, Hooks SB. Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells. 2022;11(13):2091. doi: 10.3390/cells11132091 PMID: 35805174; PMCID: PMC9266143.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatia V, Sharma S. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer’s disease. J Neurol Sci. 2021;421:117253. doi: 10.1016/j.jns.2020.117253 Epub 2020 Dec 5. PMID: 33476985.</mixed-citation><mixed-citation xml:lang="en">Bhatia V, Sharma S. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer’s disease. J Neurol Sci. 2021;421:117253. doi: 10.1016/j.jns.2020.117253 Epub 2020 Dec 5. PMID: 33476985.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Mokhber N, Shariatzadeh A, Avan A, Saber H, Babaei GS, Chaimowitz G, Azarpazhooh MR. Cerebral blood flow changes during aging process and in cognitive disorders: A review. Neuroradiol J. 2021;34(4):300–307. doi: 10.1177/19714009211002778 Epub 2021 Mar 22. PMID: 33749402; PMCID: PMC8447819.</mixed-citation><mixed-citation xml:lang="en">Mokhber N, Shariatzadeh A, Avan A, Saber H, Babaei GS, Chaimowitz G, Azarpazhooh MR. Cerebral blood flow changes during aging process and in cognitive disorders: A review. Neuroradiol J. 2021;34(4):300–307. doi: 10.1177/19714009211002778 Epub 2021 Mar 22. PMID: 33749402; PMCID: PMC8447819.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Vuralli D, Karatas H, Yemisci M, Bolay H. Updated review on the link between cortical spreading depression and headache disorders. Expert Rev Neurother. 2021;21(10):1069–1084. doi: 10.1080/14737175.202 1.1947797 Epub 2021 Sep 17. PMID: 34162288.</mixed-citation><mixed-citation xml:lang="en">Vuralli D, Karatas H, Yemisci M, Bolay H. Updated review on the link between cortical spreading depression and headache disorders. Expert Rev Neurother. 2021;21(10):1069–1084. doi: 10.1080/14737175.202 1.1947797 Epub 2021 Sep 17. PMID: 34162288.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Lin YH, Liu HM. Update on cerebral hyperperfusion syndrome. J Neurointerv Surg. 2020;12(8):788–793. doi: 10.1136/neurintsurg-2019-015621 Epub 2020 May 15. PMID: 32414892; PMCID: PMC7402457.</mixed-citation><mixed-citation xml:lang="en">Lin YH, Liu HM. Update on cerebral hyperperfusion syndrome. J Neurointerv Surg. 2020;12(8):788–793. doi: 10.1136/neurintsurg-2019-015621 Epub 2020 May 15. PMID: 32414892; PMCID: PMC7402457.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Yu W, Li Y, Hu J, Wu J, Huang Y. A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis. J Clin Med. 2022;11(16):4742. doi: 10.3390/jcm11164742 PMID: 36012981; PMCID: PMC9409771.</mixed-citation><mixed-citation xml:lang="en">Yu W, Li Y, Hu J, Wu J, Huang Y. A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis. J Clin Med. 2022;11(16):4742. doi: 10.3390/jcm11164742 PMID: 36012981; PMCID: PMC9409771.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Huang CJ, Zhou X, Yuan X, Zhang W, Li MX, You MZ, Zhu XQ, Sun ZW. Contribution of Inflammation and Hypoperfusion to White Matter Hyperintensities-Related Cognitive Impairment. Front Neurol. 2022;12:786840. doi: 10.3389/fneur.2021.786840 PMID: 35058875; PMCID: PMC8763977.</mixed-citation><mixed-citation xml:lang="en">Huang CJ, Zhou X, Yuan X, Zhang W, Li MX, You MZ, Zhu XQ, Sun ZW. Contribution of Inflammation and Hypoperfusion to White Matter Hyperintensities-Related Cognitive Impairment. Front Neurol. 2022;12:786840. doi: 10.3389/fneur.2021.786840 PMID: 35058875; PMCID: PMC8763977.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Hainsworth AH, Markus HS, Schneider JA. Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia. Hypertension. 2024;81(1):75–86. doi: 10.1161/HYPERTENSIONAHA.123.19943 Epub 2023 Nov 29. PMID: 38044814; PMCID: PMC10734789</mixed-citation><mixed-citation xml:lang="en">Hainsworth AH, Markus HS, Schneider JA. Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia. Hypertension. 2024;81(1):75–86. doi: 10.1161/HYPERTENSIONAHA.123.19943 Epub 2023 Nov 29. PMID: 38044814; PMCID: PMC10734789</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Siak J, Shufelt CL, Cook-Wiens G, Samuels B, Petersen JW, Anderson RD, Handberg EM, Pepine CJ, Merz CNB, Wei J. Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project. Vessel Plus. 2021;5:45. doi: 10.20517/2574-1209.2021.55 Epub 2021 Aug 1. PMID: 35530745; PMCID: PMC9075042.</mixed-citation><mixed-citation xml:lang="en">Siak J, Shufelt CL, Cook-Wiens G, Samuels B, Petersen JW, Anderson RD, Handberg EM, Pepine CJ, Merz CNB, Wei J. Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project. Vessel Plus. 2021;5:45. doi: 10.20517/2574-1209.2021.55 Epub 2021 Aug 1. PMID: 35530745; PMCID: PMC9075042.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, Tousoulis D. Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines. 2021;9(7):781. doi: 10.3390/biomed-icines9070781 PMID: 34356845; PMCID: PMC8301477.</mixed-citation><mixed-citation xml:lang="en">Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, Tousoulis D. Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines. 2021;9(7):781. doi: 10.3390/biomed-icines9070781 PMID: 34356845; PMCID: PMC8301477.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Brunelli N, Altamura C, Mallio CA, Lo Vullo G, Marcosano M, Bach-Pages M, Beomonte Zobel B, Quattrocchi CC, Vernieri F. Cerebral Hemodynamics, Rightto-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls. Int J Environ Res Public Health. 2022;19(14):8575. doi: 10.3390/ijerph19148575 PMID: 35886428; PMCID: PMC9318654.</mixed-citation><mixed-citation xml:lang="en">Brunelli N, Altamura C, Mallio CA, Lo Vullo G, Marcosano M, Bach-Pages M, Beomonte Zobel B, Quattrocchi CC, Vernieri F. Cerebral Hemodynamics, Rightto-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls. Int J Environ Res Public Health. 2022;19(14):8575. doi: 10.3390/ijerph19148575 PMID: 35886428; PMCID: PMC9318654.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Fang YC, Hsieh YC, Hu CJ, Tu YK. Endothelial Dysfunction in Neurodegenerative Diseases. Int J Mol Sci. 2023;24(3):2909. doi: 10.3390/ijms24032909 PMID: 36769234; PMCID: PMC9918222.</mixed-citation><mixed-citation xml:lang="en">Fang YC, Hsieh YC, Hu CJ, Tu YK. Endothelial Dysfunction in Neurodegenerative Diseases. Int J Mol Sci. 2023;24(3):2909. doi: 10.3390/ijms24032909 PMID: 36769234; PMCID: PMC9918222.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Гарбуз ДГ, Зацепина ОГ, Евгеньев МБ. Бета-амилоид, тау-белок и нейровоспаление: попытка объединения различных гипотез патогенеза болезни Альцгеймера Молекулярная биология 2021;55(5):734–747 doi: 10.31857/S0026898421050049 PMID: 34671002.</mixed-citation><mixed-citation xml:lang="en">Garbuz DG, Zatsepina OG, Evgen’ev MB. Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis]. Mol Biol (Mosk). 2021;55(5):734– 747. (In Russ.). doi: 10.31857/S0026898421050049 PMID: 34671002.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020;24(2):91–100. doi: 10.1080/14728222.2020.1724285 Epub 2020 Feb 13. PMID: 32003253; PMCID: PMC7050542.</mixed-citation><mixed-citation xml:lang="en">Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020;24(2):91–100. doi: 10.1080/14728222.2020.1724285 Epub 2020 Feb 13. PMID: 32003253; PMCID: PMC7050542.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Meade E, Garvey M. The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy. Int J Mol Sci. 2022;23(15):8574. doi: 10.3390/ijms23158574 PMID: 35955708; PMCID: PMC9369187.</mixed-citation><mixed-citation xml:lang="en">Meade E, Garvey M. The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy. Int J Mol Sci. 2022;23(15):8574. doi: 10.3390/ijms23158574 PMID: 35955708; PMCID: PMC9369187.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation. 2023;46(1):1–17. doi: 10.1007/s10753-022-01721-1 Epub 2022 Aug 20. PMID: 35986874.</mixed-citation><mixed-citation xml:lang="en">Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation. 2023;46(1):1–17. doi: 10.1007/s10753-022-01721-1 Epub 2022 Aug 20. PMID: 35986874.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Carrier M, Šimončičová E, St-Pierre MK, McKee C, Tremblay MÈ. Psychological Stress as a Risk Factor for Accelerated Cellular Aging and Cognitive Decline: The Involvement of Microglia-Neuron Crosstalk. Front Mol Neurosci. 2021;14:749737. doi: 10.3389/fnmol.2021.749737 PMID: 34803607; PMCID: PMC8599581.</mixed-citation><mixed-citation xml:lang="en">Carrier M, Šimončičová E, St-Pierre MK, McKee C, Tremblay MÈ. Psychological Stress as a Risk Factor for Accelerated Cellular Aging and Cognitive Decline: The Involvement of Microglia-Neuron Crosstalk. Front Mol Neurosci. 2021;14:749737. doi: 10.3389/fnmol.2021.749737 PMID: 34803607; PMCID: PMC8599581.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Umare MD, Wankhede NL, Bajaj KK, Trivedi RV, Taksande BG, Umekar MJ, Mahore JG, Kale MB. Interweaving of reactive oxygen species and major neurological and psychiatric disorders. Ann Pharm Fr. 2022;80(4):409–425. doi: 10.1016/j.pharma.2021.11.004 Epub 2021 Dec 9. PMID: 34896378.</mixed-citation><mixed-citation xml:lang="en">Umare MD, Wankhede NL, Bajaj KK, Trivedi RV, Taksande BG, Umekar MJ, Mahore JG, Kale MB. Interweaving of reactive oxygen species and major neurological and psychiatric disorders. Ann Pharm Fr. 2022;80(4):409–425. doi: 10.1016/j.pharma.2021.11.004 Epub 2021 Dec 9. PMID: 34896378.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Song Ke, Li Yu, Zhang H, An N, Wei Yu, Wang L, Tian Ch, Yuan M, Sun Yi, Xing Ya, Gao Yo. Oxidative StressMediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases. Oxidative medicine and cellular longevity, 2020. 2020(1):4356386.</mixed-citation><mixed-citation xml:lang="en">Song Ke, Li Yu, Zhang H, An N, Wei Yu, Wang L, Tian Ch, Yuan M, Sun Yi, Xing Ya, Gao Yo. Oxidative StressMediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases. Oxidative medicine and cellular longevity, 2020. 2020(1):4356386.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Maiese K. Migraine Disorders, Neurovascular Disease, and the Underlying Role of Oxidative Stress. Curr Neurovasc Res. 2024;21(2):111–115. doi: 10.2174/1567202621999240223164624 PMID: 38409727</mixed-citation><mixed-citation xml:lang="en">Maiese K. Migraine Disorders, Neurovascular Disease, and the Underlying Role of Oxidative Stress. Curr Neurovasc Res. 2024;21(2):111–115. doi: 10.2174/1567202621999240223164624 PMID: 38409727</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Adamo D, Canfora F, Calabria E, Coppola N, Leuci S, Pecoraro G, Cuocolo R, Ugga L, D’Aniello L, Aria M, Mignogna MD. White matter hyperintensities in Burning Mouth Syndrome assessed according to the Age-Related White Matter Changes scale. Front Aging Neurosci. 2022;14:923720. doi: 10.3389/fnagi.2022.923720 PMID: 36118686; PMCID: PMC9475000.</mixed-citation><mixed-citation xml:lang="en">Adamo D, Canfora F, Calabria E, Coppola N, Leuci S, Pecoraro G, Cuocolo R, Ugga L, D’Aniello L, Aria M, Mignogna MD. White matter hyperintensities in Burning Mouth Syndrome assessed according to the Age-Related White Matter Changes scale. Front Aging Neurosci. 2022;14:923720. doi: 10.3389/fnagi.2022.923720 PMID: 36118686; PMCID: PMC9475000.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W, Cheng Z, Fu F, Zhan Z. Prevalence and clinical characteristics of white matter hyperintensities in Migraine: A meta-analysis. Neuroimage Clin. 2023;37:103312. doi: 10.1016/j.nicl.2023.103312 Epub 2023 Jan 3. PMID: 36610309; PMCID: PMC9827384.</mixed-citation><mixed-citation xml:lang="en">Zhang W, Cheng Z, Fu F, Zhan Z. Prevalence and clinical characteristics of white matter hyperintensities in Migraine: A meta-analysis. Neuroimage Clin. 2023;37:103312. doi: 10.1016/j.nicl.2023.103312 Epub 2023 Jan 3. PMID: 36610309; PMCID: PMC9827384.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang LJ, Tian DC, Yang L, Shi K, Liu Y, Wang Y, Shi FD. White matter disease derived from vascular and demyelinating origins. Stroke Vasc Neurol. 2024;9(4):344–350. doi: 10.1136/svn-2023-002791 PMID: 37699727; PMCID: PMC11420911.</mixed-citation><mixed-citation xml:lang="en">Zhang LJ, Tian DC, Yang L, Shi K, Liu Y, Wang Y, Shi FD. White matter disease derived from vascular and demyelinating origins. Stroke Vasc Neurol. 2024;9(4):344–350. doi: 10.1136/svn-2023-002791 PMID: 37699727; PMCID: PMC11420911.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Khan W, Khlif MS, Mito R, Dhollander T, Brodtmann A. Investigating the microstructural properties of normal-appearing white matter (NAWM) preceding conversion to white matter hyperintensities (WMHs) in stroke survivors. Neuroimage. 2021;232:117839. doi: 10.1016/j.neuroimage.2021.117839 Epub 2021 Feb 9. PMID: 33577935.</mixed-citation><mixed-citation xml:lang="en">Khan W, Khlif MS, Mito R, Dhollander T, Brodtmann A. Investigating the microstructural properties of normal-appearing white matter (NAWM) preceding conversion to white matter hyperintensities (WMHs) in stroke survivors. Neuroimage. 2021;232:117839. doi: 10.1016/j.neuroimage.2021.117839 Epub 2021 Feb 9. PMID: 33577935.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Clancy U, Gilmartin D, Jochems ACC, Knox L, Doubal FN, Wardlaw JM. Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8(3):225–236. doi: 10.1016/S2215-0366(20)30431-4 Epub 2021 Feb 1. PMID: 33539776.</mixed-citation><mixed-citation xml:lang="en">Clancy U, Gilmartin D, Jochems ACC, Knox L, Doubal FN, Wardlaw JM. Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8(3):225–236. doi: 10.1016/S2215-0366(20)30431-4 Epub 2021 Feb 1. PMID: 33539776.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Hu HY, Ou YN, Shen XN, Qu Y, Ma YH, Wang ZT, Dong Q, Tan L, Yu JT. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev. 2021;120:16–27. doi: 10.1016/j.neubiorev.2020.11.007 Epub 2020 Nov 11. PMID: 33188821.</mixed-citation><mixed-citation xml:lang="en">Hu HY, Ou YN, Shen XN, Qu Y, Ma YH, Wang ZT, Dong Q, Tan L, Yu JT. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev. 2021;120:16–27. doi: 10.1016/j.neubiorev.2020.11.007 Epub 2020 Nov 11. PMID: 33188821.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Burke MJ, Joutsa J, Cohen AL, Soussand L, Cooke D, Burstein R, Fox MD. Mapping migraine to a common brain network. Brain. 2020;143(2):541–553. doi: 10.1093/brain/awz405 PMID: 31919494; PMCID: PMC7009560.</mixed-citation><mixed-citation xml:lang="en">Burke MJ, Joutsa J, Cohen AL, Soussand L, Cooke D, Burstein R, Fox MD. Mapping migraine to a common brain network. Brain. 2020;143(2):541–553. doi: 10.1093/brain/awz405 PMID: 31919494; PMCID: PMC7009560.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Ashina S, Bentivegna E, Martelletti P, Eikermann-Haerter K. Structural and Functional Brain Changes in Migraine. Pain Ther. 2021;10(1):211–223. doi: 10.1007/s40122-021-00240-5 Epub 2021 Feb 16. PMID: 33594593; PMCID: PMC8119592..</mixed-citation><mixed-citation xml:lang="en">Ashina S, Bentivegna E, Martelletti P, Eikermann-Haerter K. Structural and Functional Brain Changes in Migraine. Pain Ther. 2021;10(1):211–223. doi: 10.1007/s40122-021-00240-5 Epub 2021 Feb 16. PMID: 33594593; PMCID: PMC8119592..</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Risacher SL, Apostolova LG. Neuroimaging in Dementia. Continuum (Minneap Minn). 2023;29(1):219–254. doi: 10.1212/CON.0000000000001248 PMID: 36795879.</mixed-citation><mixed-citation xml:lang="en">Risacher SL, Apostolova LG. Neuroimaging in Dementia. Continuum (Minneap Minn). 2023;29(1):219–254. doi: 10.1212/CON.0000000000001248 PMID: 36795879.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Russo M, De Rosa MA, Calisi D, Consoli S, Evangelista G, Dono F, Santilli M, Granzotto A, Onofrj M, Sensi SL. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits. Int J Mol Sci. 2022;23(19):11418. doi: 10.3390/ijms231911418 PMID: 36232720; PMCID: PMC9569564.</mixed-citation><mixed-citation xml:lang="en">Russo M, De Rosa MA, Calisi D, Consoli S, Evangelista G, Dono F, Santilli M, Granzotto A, Onofrj M, Sensi SL. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits. Int J Mol Sci. 2022;23(19):11418. doi: 10.3390/ijms231911418 PMID: 36232720; PMCID: PMC9569564.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Begasse de Dhaem O, Robbins MS. Cognitive Impairment in Primary and Secondary Headache Disorders. Curr Pain Headache Rep. 2022;26(5):391–404. doi: 10.1007/s11916-022-01039-5 Epub 2022 Mar 3. PMID: 35239156; PMCID: PMC8891733.</mixed-citation><mixed-citation xml:lang="en">Begasse de Dhaem O, Robbins MS. Cognitive Impairment in Primary and Secondary Headache Disorders. Curr Pain Headache Rep. 2022;26(5):391–404. doi: 10.1007/s11916-022-01039-5 Epub 2022 Mar 3. PMID: 35239156; PMCID: PMC8891733.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal, NT, Dafer RM. Neurological diseases: Sex and gender evidence in stroke, migraine, and Alzheimer’s dementia,In:How Sex and Gender Impact Clinical Practice. Elsevier. 2021:229–258.</mixed-citation><mixed-citation xml:lang="en">Aggarwal, NT, Dafer RM. Neurological diseases: Sex and gender evidence in stroke, migraine, and Alzheimer’s dementia,In:How Sex and Gender Impact Clinical Practice. Elsevier. 2021:229–258.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, Hoyle R, Bien-Ly N, Silverman AP, Sullivan PM, Watts RJ, Ulrich JD, Zipfel GJ, Holtzman DM. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13(581):eabd7522. doi: 10.1126/scitranslmed.abd7522 PMID: 33597265; PMCID: PMC8128342.</mixed-citation><mixed-citation xml:lang="en">Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, Hoyle R, Bien-Ly N, Silverman AP, Sullivan PM, Watts RJ, Ulrich JD, Zipfel GJ, Holtzman DM. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13(581):eabd7522. doi: 10.1126/scitranslmed.abd7522 PMID: 33597265; PMCID: PMC8128342.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Q, Zhang C, Wu S, He Y, Liu Y, Zheng L, Li B, Liu G, Liu L. Genetic evidence for causal association between migraine and dementia: a mendelian randomization study. BMC Med Genomics. 2024;17(1):180. doi: 10.1186/s12920-024-01956-x PMID: 38970023; PMCID: PMC11229492.</mixed-citation><mixed-citation xml:lang="en">Chen Q, Zhang C, Wu S, He Y, Liu Y, Zheng L, Li B, Liu G, Liu L. Genetic evidence for causal association between migraine and dementia: a mendelian randomization study. BMC Med Genomics. 2024;17(1):180. doi: 10.1186/s12920-024-01956-x PMID: 38970023; PMCID: PMC11229492.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Terwindt G, Kors E, Haan J, Vermeulen F, Van den Maagdenberg A, Frants R, Ferrari M. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol. 2002;59(6):1016–1018. doi: 10.1001/archneur.59.6.1016 PMID: 12056940.</mixed-citation><mixed-citation xml:lang="en">Terwindt G, Kors E, Haan J, Vermeulen F, Van den Maagdenberg A, Frants R, Ferrari M. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol. 2002;59(6):1016–1018. doi: 10.1001/archneur.59.6.1016 PMID: 12056940.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Nardello R, Plicato G, Mangano GD, Gennaro E, Mangano S, Brighina F, Raieli V, Fontana A. Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurol. 2020;20(1):155. doi: 10.1186/s12883-020-01704-5 PMID: 32336275; PMCID: PMC7183684.</mixed-citation><mixed-citation xml:lang="en">Nardello R, Plicato G, Mangano GD, Gennaro E, Mangano S, Brighina F, Raieli V, Fontana A. Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurol. 2020;20(1):155. doi: 10.1186/s12883-020-01704-5 PMID: 32336275; PMCID: PMC7183684.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Sudershan A, Mahajan K, Singh K, Dhar MK, Kumar P. The complexities of migraine: A debate among migraine researchers: A review. Clin Neurol Neurosurg. 2022;214:107136. doi: 10.1016/j.clineuro.2022.107136 Epub 2022 Jan 19. PMID: 35101780..</mixed-citation><mixed-citation xml:lang="en">Sudershan A, Mahajan K, Singh K, Dhar MK, Kumar P. The complexities of migraine: A debate among migraine researchers: A review. Clin Neurol Neurosurg. 2022;214:107136. doi: 10.1016/j.clineuro.2022.107136 Epub 2022 Jan 19. PMID: 35101780..</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J, Ha WS, Park SH, Han K, Baek MS. Association between migraine and Alzheimer’s disease: a nationwide cohort study. Front Aging Neurosci. 2023;15:1196185. doi: 10.3389/fnagi.2023.1196185 PMID: 37304073; PMCID: PMC10248237.</mixed-citation><mixed-citation xml:lang="en">Kim J, Ha WS, Park SH, Han K, Baek MS. Association between migraine and Alzheimer’s disease: a nationwide cohort study. Front Aging Neurosci. 2023;15:1196185. doi: 10.3389/fnagi.2023.1196185 PMID: 37304073; PMCID: PMC10248237.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Prajjwal P, Marsool MDM, Inban P, Sharma B, Asharaf S, Aleti S, Gadam S, Al Sakini AS, Hadi DD. Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer’s dementia and diabetes mellitus. Dis Mon. 2023;69(5):101557. doi: 10.1016/j.disamonth.2023.101557 Epub 2023 Apr 6. PMID: 37031059.</mixed-citation><mixed-citation xml:lang="en">Prajjwal P, Marsool MDM, Inban P, Sharma B, Asharaf S, Aleti S, Gadam S, Al Sakini AS, Hadi DD. Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer’s dementia and diabetes mellitus. Dis Mon. 2023;69(5):101557. doi: 10.1016/j.disamonth.2023.101557 Epub 2023 Apr 6. PMID: 37031059.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Eikermann-Haerter K, Huang SY. White Matter Lesions in Migraine. Am J Pathol. 2021;191(11):1955–1962. doi: 10.1016/j.ajpath.2021.02.007 Epub 2021 Feb 24. PMID: 33636178.</mixed-citation><mixed-citation xml:lang="en">Eikermann-Haerter K, Huang SY. White Matter Lesions in Migraine. Am J Pathol. 2021;191(11):1955–1962. doi: 10.1016/j.ajpath.2021.02.007 Epub 2021 Feb 24. PMID: 33636178.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Pike KE, Cavuoto MG, Li L, Wright BJ, Kinsella GJ. Subjective Cognitive Decline: Level of Risk for Future Dementia and Mild Cognitive Impairment, a Meta-Analysis of Longitudinal Studies. Neuropsychol Rev. 2022;32(4):703–735. doi: 10.1007/s11065-021-09522-3 Epub 2021 Nov 8. PMID: 34748154.</mixed-citation><mixed-citation xml:lang="en">Pike KE, Cavuoto MG, Li L, Wright BJ, Kinsella GJ. Subjective Cognitive Decline: Level of Risk for Future Dementia and Mild Cognitive Impairment, a Meta-Analysis of Longitudinal Studies. Neuropsychol Rev. 2022;32(4):703–735. doi: 10.1007/s11065-021-09522-3 Epub 2021 Nov 8. PMID: 34748154.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng B, Su B, Udeh-Momoh C, Price G, Tzoulaki I, Vamos EP, Majeed A, Riboli E, Ahmadi-Abhari S, Middleton LT. Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study. J Prev Alzheimers Dis. 2022;9(1):86–91. doi: 10.14283/jpad.2022.8 PMID: 35098977.</mixed-citation><mixed-citation xml:lang="en">Zheng B, Su B, Udeh-Momoh C, Price G, Tzoulaki I, Vamos EP, Majeed A, Riboli E, Ahmadi-Abhari S, Middleton LT. Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study. J Prev Alzheimers Dis. 2022;9(1):86–91. doi: 10.14283/jpad.2022.8 PMID: 35098977.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Panay N, Anderson RA, Nappi RE, Vincent AJ, Vujovic S, Webber L, Wolfman W. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446. doi: 10.1080/13697137.2020.1804547 Epub 2020 Sep 8. PMID: 32896176.</mixed-citation><mixed-citation xml:lang="en">Panay N, Anderson RA, Nappi RE, Vincent AJ, Vujovic S, Webber L, Wolfman W. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446. doi: 10.1080/13697137.2020.1804547 Epub 2020 Sep 8. PMID: 32896176.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Pelzer N, de Boer I, van den Maagdenberg AMJM, Terwindt GM. Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives. Cephalalgia. 2023;43(6):3331024231180564. doi: 10.1177/03331024231180564 PMID: 37293935.</mixed-citation><mixed-citation xml:lang="en">Pelzer N, de Boer I, van den Maagdenberg AMJM, Terwindt GM. Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives. Cephalalgia. 2023;43(6):3331024231180564. doi: 10.1177/03331024231180564 PMID: 37293935.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Buse DC, Yugrakh MS, Lee LK, Bell J, Cohen JM, Lipton RB. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine. J Manag Care Spec Pharm. 2020;26(10):1334– 1343. doi: 10.18553/jmcp.2020.20100 Epub 2020 Jul 17. PMID: 32678721; PMCID: PMC10391061.</mixed-citation><mixed-citation xml:lang="en">Buse DC, Yugrakh MS, Lee LK, Bell J, Cohen JM, Lipton RB. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine. J Manag Care Spec Pharm. 2020;26(10):1334– 1343. doi: 10.18553/jmcp.2020.20100 Epub 2020 Jul 17. PMID: 32678721; PMCID: PMC10391061.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Kong F, Buse DC. Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies. Cephalalgia. 2020;40(5):503–516. doi: 10.1177/0333102419883355 Epub 2019 Oct 21. PMID: 31635478.</mixed-citation><mixed-citation xml:lang="en">Xu J, Kong F, Buse DC. Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies. Cephalalgia. 2020;40(5):503–516. doi: 10.1177/0333102419883355 Epub 2019 Oct 21. PMID: 31635478.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Schramm SH, Tenhagen I, Jokisch M, Gronewold J, Moebus S, Caspers S, Katsarava Z, Erbel R, Stang A, Schmidt B. Migraine or any headaches and white matter hyperintensities and their progression in women and men. J Headache Pain. 2024;25(1):78. doi: 10.1186/s10194-024-01782-7</mixed-citation><mixed-citation xml:lang="en">Schramm SH, Tenhagen I, Jokisch M, Gronewold J, Moebus S, Caspers S, Katsarava Z, Erbel R, Stang A, Schmidt B. Migraine or any headaches and white matter hyperintensities and their progression in women and men. J Headache Pain. 2024;25(1):78. doi: 10.1186/s10194-024-01782-7</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao L, Tang Y, Tu Y, Cao J. Genetic evidence for the causal relationships between migraine, dementia, and longitudinal brain atrophy. J Headache Pain. 2024;25(1):93. doi: 10.1186/s10194-024-01801-7</mixed-citation><mixed-citation xml:lang="en">Zhao L, Tang Y, Tu Y, Cao J. Genetic evidence for the causal relationships between migraine, dementia, and longitudinal brain atrophy. J Headache Pain. 2024;25(1):93. doi: 10.1186/s10194-024-01801-7</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
